Cantor Fitzgerald analysts increased the price target for Etsy, Inc. (NASDAQ:ETSY) from $47 to $52 and kept a “Neutral” ...

Cantor Fitzgerald’s latest Bi-Weekly Trading Report paints a cautiously defensive outlook for the equities market over the ...

Cantor Fitzgerald raised the firm’s price target on Phathom Pharmaceuticals (PHAT) to $29 from $23 and keeps an Overweight rating on the shares.

Cantor Fitzgerald, a financial services firm, that it entered into a definitive agreement to acquire UBS’s O’Connor ...

The Cantor Fitzgerald Gold Protected Bitcoin Fund, which the firm said will be its first BTC-focused investment vehicle, is ...

Cantor Fitzgerald analysts reaffirmed their price target of $71 and Overweight rating on CVS Health Corporation (NYSE:CVS) on ...

Cantor Fitzgerald LP agreed to buy UBS Group AG’s O’Connor unit, ending more than three decades of ownership by the Swiss ...

Cantor Fitzgerald analyst Colin Canfield maintained a Buy rating on Planet Labs PBC (PL – Research Report) yesterday and set a price target of $6.30. The company’s shares clos ...

Cantor Fitzgerald lowered the firm’s price target on Elastic (ESTC) to $92 from $109 and keeps a Neutral rating on the shares ...

Cantor Fitzgerald is debuting a new gold-backed Bitcoin fund for investors scared of the cryptocurrency's volatility.

Cantor Fitzgerald analyst Sarah James reiterated a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $71.00. The company’s shares opened today a ...

Cantor Fitzgerald’s gold-backed Bitcoin fund may attract billions in cautious capital, stabilizing BTC while institutional ...